Labcorp (LH) Competitors

Labcorp (NYSE:LH) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends.

Do analysts rate LH or HOLX?

Labcorp currently has a consensus price target of $276.08, suggesting a potential upside of 5.42%. Hologic has a consensus price target of $77.42, suggesting a potential upside of 19.59%. Given Hologic's higher possible upside, analysts clearly believe Hologic is more favorable than Labcorp.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Labcorp	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.79
Hologic	0 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.41

Do insiders & institutionals hold more shares of LH or HOLX?

95.9% of Labcorp shares are held by institutional investors. Comparatively, 94.7% of Hologic shares are held by institutional investors. 0.8% of Labcorp shares are held by insiders. Comparatively, 1.9% of Hologic shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Is LH or HOLX more profitable?

Hologic has a net margin of 13.83% compared to Labcorp's net margin of 5.55%. Hologic's return on equity of 19.71% beat Labcorp's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Labcorp	5.55%	15.27%	6.97%
Hologic	13.83%	19.71%	10.87%

Which has more risk and volatility, LH or HOLX?

Labcorp has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.

Does the media prefer LH or HOLX?

In the previous week, Labcorp had 3 more articles in the media than Hologic. MarketBeat recorded 16 mentions for Labcorp and 13 mentions for Hologic. Labcorp's average media sentiment score of 1.26 beat Hologic's score of 1.26 indicating that Labcorp is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Labcorp	12 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hologic	10 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable earnings & valuation, LH or HOLX?

Hologic has lower revenue, but higher earnings than Labcorp. Hologic is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Labcorp	$13.01B	1.69	$746M	$8.65	30.28
Hologic	$4.03B	3.58	$789.50M	$2.37	27.31

Summary

Labcorp beats Hologic on 9 of the 16 factors compared between the two stocks.